city Columbia hospital testing symptoms patient city Columbia

Experimental schizophrenia drug could reduce long-neglected symptoms

Reading now: 951
www.sciencemag.org

By Kelly ServickFor the first time in decades, researchers may have a new way to tweak brain signals to treat psychosis and other symptoms of schizophrenia.

Results from a 245-person clinical trial hint that a compound called SEP-363856, which seems to act on neural receptors involved in dopamine signaling, might address a broader range of schizophrenia symptoms than currently available drugs do—and with fewer side effects.“If these results are confirmed, this will be big, big news,” says Jeffrey Lieberman, a psychiatrist at Columbia University.

The drug’s developer, Sunovion Pharmaceuticals Inc., identified it through an unusual screening process not guided by the brain circuits and receptors already implicated in the disease, Lieberman

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA